GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.3 billion, respectively.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
SoFi crushed revenue estimates and raised its top-line outlook, yet shares cratered 10% anyway as sellers zeroed in on one number management refused to budge on.
QRVO tops Q1 earnings and revenue estimates despite lower smartphone-related sales, as strong growth in High-Performance Analog and disciplined cost management lift margins.
The Tim Cook era was a highly profitable one for Apple shareholders.
PENN, CSV, GM and AMN emerge as late-2026 value picks, supported by attractive valuations, earnings growth and cash-flow strength.
VMC's second-quarter 2026 earnings and revenues beat estimates as pricing gains, higher aggregates volumes and cost control help offset energy inflation.
Under the terms of the agreement, POSCO could receive up to 30% of Caldeira’s rare earth material for a period of up to seven years.
After a mixed day yesterday, stocks are under modest pressure ahead of a key monetary policy meeting. Crude oil is spiking, putting downward pressure on gold and silver, while Treasuries and the dollar are mostly flat.
During an interview with CNBC, Wolfe Research analyst Chris Caso expressed concern that this backstop strategy creates liabilities that leave him “less comfortable.”
ANET heads into Q2 earnings with strong AI networking momentum, rising estimates and a likely beat, though its premium valuation raises the stakes.
Xeltis recently secured an additional €20.5 million in funding led by Horizon 3 Healthcare, with DaVita participating to help advance the aXess™ vascular access platform through US trials, regulatory submissions, and European rollout. Alongside this investment, investor attention has intensified around DaVita’s upcoming August 2026 earnings report and its initiatives to expand equitable access to kidney care, including home dialysis and transplant support. With DaVita’s recent returns in...
GNRC's Q2 earnings beat estimates as C&I growth, data center demand and tariff refunds have lifted results, while its 2026 sales outlook is reaffirmed.
Earlier this month, Deckers Outdoor reported first-quarter 2026 sales of US$1,019.53 million with net income of US$129.97 million, and raised its full-year fiscal 2027 guidance to net sales of US$5.86–5.91 billion, operating margin slightly above 21.5%, and diluted EPS of US$7.35–7.50, assuming share repurchases equal to roughly 80% of projected free cash flow. Alongside the guidance upgrade, Deckers’ Teva division rolled out an extensive Fall 2026 performance and lifestyle lineup, including...
(Bloomberg) -- As Big Tech barrels toward trillions of dollars of planned spending on AI, a key cog in credit markets is showing signs of pressure. That, in turn, is lifting the cost of financing artificial intelligence while offering an early look at potential winners and losers.Most Read from BloombergUS Intercepts Iran Attack on Bases, Puncturing Days of CalmSK Hynix Profit Disappoints, Spending Soars to $31 BillionApple Set to Make Big Smart Home Push With Siri AI at CenterNvidia’s $750 Bill
Seagate Technology Holdings PLC (NASDAQ:STX) shares rose about 2% on Wednesday after the data storage company reported fiscal fourth quarter results that exceeded Wall Street expectations on both earnings and revenue and issued guidance that pointed to continued momentum. For the quarter...
Oracle stock has fallen 38% so far this year, and further sell-offs could be in store.
It takes a lot for artificial-intelligence trade-related companies to impress Wall Street with earnings or guidance these days, but Teradyne has done just that. Shares of the semiconductor test equipment manufacturer rose 9% to $338.43 on Wednesday after the company late Tuesday reported better-than-expected second-quarter earnings and solid quarterly guidance. Teradyne posted adjusted earnings of $2.47 a share in the second quarter, up from 57 cents a year ago and well above Wall Street’s expectation of $2.09.
Eos Energy Enterprises (EOSE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Duolingo (DUOL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DAVE INC (DAVE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cirrus Logic (CRUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Block (XYZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axon (AXON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Regal Rexnord (RRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Motorola (MSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kraft Heinz (KHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Howard Hughes Holdings (HHH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Figma, Inc. (FIG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amdocs (DOX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.